Streetbeat News

Products Services

ASND

Ascendia Pharma shares are trading higher following the FDA approval of YORVIPATH for treating hypoparathyroidism in adults.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:13 pm

AVBP

ArriVent BioPharma, Inc. (NASDAQ: AVBP) will present interim Phase 1b data for firmonertinib, a treatment for EGFR PACC mutant non-small cell lung cancer, at the 2024 World Conference on Lung Cancer. The presentation will be part of the presidential session, and ArriVent will also host a virtual webinar on September 9, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:10 pm

INAB

IN8bio shares are trading higher following the announcement of updated clinical data from its Phase 1 trials of INB-100 and receiving FDA guidance on a registration path for INB-100.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:08 pm

INAB

IN8bio has announced clinical data from Phase 1 trials of INB-100 in Acute Myeloid Leukemia (AML) and INB-200 in Glioblastoma Multiforme (GBM). The company has also received FDA guidance on the registrational path for INB-100, with an IND submission expected in Q1 2025. This solidifies IN8bio's position as a leader in gamma-delta T cell therapy for oncology.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:07 pm

EXK

Endeavour Silver shares are trading lower after the company announced a significant equipment failure at the Guanacevi mill, which could take up to 12 weeks to replace. The processing of material at the mill has been suspended.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:06 pm

NKLA

Nikola Corporation is continuing to deliver HYLA refueling solutions to support the ramp-up of Class 8 hydrogen fuel cell electric trucks in Southern California along the 5 Freeway.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:06 pm

META

Meta and Universal Music Group have announced an expanded global multi-year agreement to enhance creative and commercial opportunities for UMG artists and songwriters across Meta platforms, including Facebook, Instagram, Messenger, Horizon, Threads, and WhatsApp.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:05 pm

MSTR

MicroStrategy shares fell by 3.10% in pre-market trading, reflecting Bitcoin's performance near $58,000. The company's strong association with Bitcoin has led to significant stock returns but also exposes it to cryptocurrency market volatility.

Portfolio Pulse from Benzinga Neuro

August 12, 2024 | 12:05 pm

EXK

Endeavour Silver shares are trading lower after the company announced a significant equipment failure at the Guanacevi mill, leading to a suspension of material processing for up to 12 weeks.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:05 pm

AEMD

Aethlon Medical has received ethics approval to conduct a clinical trial of its Hemopurifier in patients with solid tumors unresponsive to anti-PD-1 therapy. The trial will take place at Pindara Private Hospital in Queensland, Australia.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 12:03 pm